Maalox TC · DIN 02162369 · 120 mg & 60 mg/mL · oral liquid
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2002-08-07 — choose a marketed DIN from the same-category list.Discontinued August 7, 2002 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2002-08-07 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2002-08-07 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Maalox TC · DIN 02162369
Manufacturer: Novartis Pharma Canada Inc.; listing date 1998-03-17
Health Canada: Cancelled post market since 2002-08-07 · brand MAALOX TC SUSPENSION · ATC A02AD01 ORDINARY SALT COMBINATIONS · form Suspension · route Oral · ingredients ALUMINUM HYDROXIDE 600 MG/5ML, MAGNESIUM HYDROXIDE 300 MG/5ML · company Novartis consumer health canada inc. · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product recordMaalox TC: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02162369)
Source record
DIN 02162369: Maalox TC
Raw flags: notABenefit=Y, sec3=Y
Item: 560400016; group id 645; item number 1623; lccId None; manufacturer id NOV
Source form: O/L; strength: 120mg & 60mg/mL
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02162369
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=20087
Interchangeable products
Diovol EX · DIN 00491217 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02162369
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since August 7, 2002 — choose a marketed DIN from the same-category list.